SCHEMBL1897264

SCHEMBL1897264

CCOCC(=O)Nc1cnc2ccccc2c1NCCOCCS(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 6/20 0.39
POLB P06746 2/20 0.39
ALDH1A1 P00352 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
HSD17B10 Q99714 1/20 0.38
TOP2A P11388 4/20 0.38
AURKA O14965 2/20 0.37
AURKB Q96GD4 2/20 0.37
MAPT P10636 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TSHR P16473 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1896074 0.87 MAP4K4 (0.38) MEN1PKMKMT2AKDM4EPOLB
Hydrochloric Acid SCHEMBL1895255 0.85 ALDH1A1 (0.42) MEN1PKMKMT2AKDM4EALDH1A1
SCHEMBL4308968 0.81 MEN1 (0.45) MEN1PKMKMT2AKDM4EPOLB
Hydrochloric Acid SCHEMBL4315442 0.81 MEN1 (0.45) MEN1PKMKMT2AKDM4EPOLB
SCHEMBL1895375 0.78 KDM4E (0.44) MEN1PKMKMT2AKDM4EPOLB
Hydrochloric Acid SCHEMBL1141137 0.78 MEN1 (0.43) MEN1PKMKMT2AKDM4EPOLB
SCHEMBL1897056 0.77 KDM4E (0.42) MEN1PKMKMT2AKDM4EPOLB
SCHEMBL18183187 0.76 KDM4E (0.50) MEN1PKMKMT2AKDM4EPOLB
SCHEMBL18179116 0.76 BRD4 (0.41) MEN1PKMKMT2ANPC1RAB9A
SCHEMBL22347101 0.76 BRD4 (0.41) MEN1PKMKMT2ABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939526-B2 Sulfone substituted imidazo ring ethers 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-05-10 US disclosed
US-20070155767-A1 Sulfone substituted imidazo ring ethers 3M INNOVATIVE PROPERTIES COMPANY 2007-07-05 US disclosed
EP-1694674-A2 SULFONE SUBSTITUTED IMIDAZO RING ETHERS 3M Innovative Properties Company (US) 2006-08-30 EP disclosed
WO-2005076783-A2 SULFONE SUBSTITUTED IMIDAZO RING ETHERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155767-A1 Sulfone substituted imidazo ring ethers IL2, IL4, IFNG MEN1 3916/4885PKM 3546/4885KMT2A 2878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.